Anaptysbio, Inc
ANAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001370053
In the last 90 days, Anaptysbio, Inc insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Anaptysbio, Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 122 | 1 | 127 | +6 |
| Shares | 27.8M | 14.9K | 27.6M | −165.0K (−0.6%) |
| Value | $720.6M | $387.0K | $748.8M | +$28.5M (+4.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Anaptysbio, Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blackstone Group Inc. | 328,720 | $8.91M | 0.02% |
| Eversept Partners, LP | 78,054 | $2.12M | 0.17% |
| Bank of Montreal | 50,660 | $1.35M | 0.00% |
| Fisher Asset Management, LLC | 46,019 | $1.25M | 0.00% |
| Ensign Peak Advisors, Inc | 43,442 | $1.18M | 0.00% |
| Ziegler Capital Management, LLC | 33,205 | $901.0K | 0.03% |
| Franklin Resources Inc | 14,900 | $404.0K | 0.00% |
| Gsa Capital Partners LLP | 14,583 | $395.0K | 0.04% |
| Jump Financial, LLC | 11,900 | $323.0K | 0.02% |
| Winton Group Ltd | 11,487 | $312.0K | 0.02% |
| SEI Investments Co | 7,835 | $212.0K | 0.00% |
| Pinz Capital Management, LP | 6,900 | $187.0K | 0.08% |
| Lazard Asset Management LLC | 2,242 | $60.0K | 0.00% |
| Quantbot Technologies LP | 800 | $21.0K | 0.00% |
| Total Clarity Wealth Management, Inc. | 350 | $9.00K | 0.00% |
Sold out (9)
Institutions that held Anaptysbio, Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Voloridge Investment Management, LLC | 44,975 | $1.17M |
| Ikarian Capital, LLC | 21,553 | $558.0K |
| Ergoteles LLC | 11,400 | $296.0K |
| Tudor Investment Corp Et Al | 10,902 | $283.0K |
| Krensavage Asset Management, LLC | 10,890 | $282.0K |
| Engineers Gate Manager LP | 10,840 | $281.0K |
| Group One Trading, L.P. | 5,920 | $154.0K |
| FORA Capital, LLC | 2,536 | $66.0K |
| Dark Forest Capital Management LP | 2,360 | $61.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Anaptysbio, Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 14,900 | $387.0K |